Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSupreme Plc Regulatory News (SUP)

Share Price Information for Supreme Plc (SUP)

Share Price is delayed by 15 minutes
Get Live Data
148.00    -6.00 (-4.11%)
Bid:
146.00
Ask:
150.00
Spread: 4.00 (2.74%)
Market Cap: £164.24m
SUP Live PriceLast checked at - London Stock Exchange

Intraday Supreme Plc Share Chart

Year End Trading Update

17 Apr 2023 07:00

RNS Number : 3462W
Supreme PLC
17 April 2023
 

17 April 2023

 

Supreme plc

 

("Supreme," the "Company" or the "Group")

(AIM: SUP)

 

Year End Trading Update

 

Trading for FY23 ahead of consensus expectations2, driven by organic and acquisitive growth

The Company now anticipates trading in FY24 will be slightly ahead of current consensus expectations3.

 

The Board of Supreme, a leading manufacturer, supplier, and brand owner of fast-moving consumer products, is delighted to announce a trading update for the twelve months ended 31 March 2023 ("FY23"). Results for the period will be announced on Wednesday 5 July 2023.

 

Supreme has performed strongly throughout the second half of FY23, delivering organic growth across its core business, supplemented by the earnings from the two vaping acquisitions completed in the first half of the year.

 

The Company expects to report FY23 revenue of at least £150 million (2022: £130.8 million) and Adjusted EBITDA1 of at least £19.3 million (2022: £21.1 million), comfortably ahead of current market expectations2.

 

The Group's Vaping category has delivered another excellent performance, nearly doubling revenues from £43.5 million in FY22 to around £75.0 million in FY23. This record performance, underpinned by the Group's core 88Vape brand, has been buoyed by a number of earnings accretive acquisitions in the period, alongside strong new customer momentum, increased market share on e-liquids and favourable market conditions.

 

The remainder of the Group remains profitable and resilient with the Lighting category showing ongoing signs of recovery.

 

The Company expects bank borrowings net of cash to be neutral as at 31 March 2023, a reduction of £12.9 million since the half year, a reminder of the highly cash-generative nature of the Supreme platform.

 

Last week, Supreme was encouraged to hear of the Government's continued support for Vaping as the "the most effective" smoking cessation tool and the launch of its national "swap to stop campaign" where the government plans to provide vape starter kits to support one million adults to quit smoking over the next two years. Supreme's long-standing and overarching company strategy is to support a tobacco-free Great Britain by offering both credible and safer alternatives to nicotine consumption.

Outlook

 

Looking at FY24, the Group expects to maintain its strong growth trajectory, delivering another strong year of profitable growth. The Group now expects trading for the year ended 31 March 2024 to be slightly ahead of current market expectations3.

 

The Board remains confident that the Group will continue to deliver both organic and acquisition led growth this financial year and beyond.

 

1Adjusted EBITDA means operating profit before depreciation, amortisation, share-based payments charge, fair value movements on non-hedge accounted derivatives and exceptional items (including IPO-related costs).

 

2Company compiled analyst consensus for the year ending 31 March 2023 prior to release of this announcement were revenues of £138 million and Adjusted EBITDA of £18.5 million.

3Company compiled analyst consensus for the year ending 31 March 2024 prior to release of this announcement were revenues of £150.5 million and Adjusted EBITDA of £22.2million.

 

Enquiries:

 

Supreme plc

Sandy Chadha, Chief Executive Officer

Suzanne Smith, Chief Finance Officer

 

via Vigo Consulting

Grant Thornton UK LLP (Nominated Adviser)

Samantha Harrison / Harrison Clarke / Samuel Littler

 

+44 (0)20 7383 5100

Berenberg (Broker)

Mark Whitmore / Marie Moy / Mara Grasso

 

+44 (0)20 3207 7800

Vigo Consulting (Financial Public Relations)

Jeremy Garcia / Kendall Hill

supreme@vigoconsulting.com

+44 (0)20 7390 0230

 

The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014 which is part of UK law by virtue of the European Union (withdrawal) Act 2018. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

 

About Supreme

 

Supreme supplies products across five key categories; batteries, lighting, vaping, sports nutrition & wellness, and branded household consumer goods. The Company's capabilities span from product development and manufacturing through to its extensive retail distribution network and direct to consumer capabilities. This vertically integrated platform provides an excellent route to market for well-known brands and products.

 

The Group has over 3,300 active business accounts with retail customers who manage over 10,000 branded retail outlets. Customers include B&M, Home Bargains, Poundland, Tesco, Sainsburys, Morrisons, Amazon, The Range, Costcutter, Asda, Halfords, Iceland and HM Prison & Probation Service.

 

In addition to distributing globally-recognised brands such as Duracell, Energizer and Panasonic, and supplying lighting products exclusively under the Energizer, Eveready, Black & Decker and JCB licences across 45 countries, Supreme has also developed brands in-house, most notably 88Vape and has a growing footprint in Sports Nutrition and Wellness via its principal brands Sci-MX and Battle Bites.

 

www.investors.supreme.co.uk

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFFFVLSTIRLIV
Date   Source Headline
20th May 20267:00 amRNSNotice of Results and Investor Presentation
7th May 20267:00 amRNS-RNEW LICENSING AGREEMENT
21st Apr 20267:00 amRNS-RNEW LICENSING AGREEMENT
20th Apr 20267:00 amRNSTrading Statement
19th Feb 20265:00 pmRNSHolding(s) in Company
19th Feb 20264:55 pmRNSHolding(s) in Company
19th Feb 20264:50 pmRNSHolding(s) in Company
19th Feb 20264:45 pmRNSHolding(s) in Company
19th Feb 20264:41 pmRNSHolding(s) in Company
12th Jan 20265:18 pmRNSHolding(s) in Company
2nd Jan 20267:00 amRNSBlock Admission Return
2nd Jan 20267:00 amRNSBlock Admission Return
2nd Dec 20257:00 amRNSDirector/PDMR Shareholding
25th Nov 20257:00 amRNSHalf-year Results
31st Oct 20257:00 amRNSNotice of Results & Investor Presentation
20th Oct 202510:30 amRNSAcquisition of SlimFast UK & Europe
18th Sep 202511:04 amRNSResult of AGM
18th Sep 20257:00 amRNSAGM Trading Statement
1st Sep 20257:00 amRNSAcquisition of 1001 carpet care brand
19th Aug 20257:00 amRNSPosting of Annual Report & Notice of AGM
10th Jul 20257:00 amRNSGrant of Options
2nd Jul 20259:29 amRNSHolding(s) in Company
1st Jul 20257:01 amRNSBlock Admission Return
1st Jul 20257:00 amRNSFinal Results
30th Jun 20257:00 amRNSTotal Voting Rights
12th Jun 20257:00 amRNSNotice of Results & Investor Presentation
29th May 20259:46 amRNSHolding(s) in Company
23rd Apr 20257:00 amRNSTrading Update
28th Feb 20257:00 amRNSTotal Voting Rights
31st Jan 20257:00 amRNSTotal Voting Rights
2nd Jan 20251:57 pmRNSHolding(s) in Company
2nd Jan 20257:00 amRNSBlock Admission Return
31st Dec 20247:00 amRNSTotal Voting Rights
2nd Dec 20247:00 amRNSAcquisition of Typhoo Tea for £10.2 million
28th Nov 20243:11 pmRNSPotential Acquisition of Typhoo Tea
26th Nov 20247:00 amRNSHalf-year Results
25th Oct 20247:00 amRNSNotice of Results & Investor Presentation
14th Oct 20247:00 amRNSDirector/PDMR Shareholding
19th Sep 202412:29 pmRNSResult of AGM
19th Sep 20247:00 amRNSAGM Trading Statement
30th Aug 20247:00 amRNSTotal Voting Rights
27th Aug 20247:00 amRNSAvailability of Annual Report & Notice of AGM
5th Jul 202412:26 pmRNSBlock Admission Return
2nd Jul 20247:00 amRNSFinal Results
28th Jun 20247:00 amRNSTotal Voting Rights
24th Jun 20247:00 amRNSAcquisition of Clearly Drinks Limited for £15m
12th Jun 20247:00 amRNSNotice of Results & Investor Presentation
31st May 20247:00 amRNSTotal Voting Rights
24th Apr 20247:00 amRNSYear End Trading Update
28th Mar 20247:00 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.